title: Expansion of CD57 and CD62L-CD45RA+ CD8 T lymphocytes correlates with reduced viral plasma RNA after primary HIV infection.
abstract: OBJECTIVE
  CD8 T cells, expressing cell surface molecules distinct from those on resting and naive T cells, are increased in HIV infection. The association of increased CD38 and human leukocyte antigen DR (HLA-DR) CD8 T cells with poor prognosis has suggested that activated CD8 T cells may aggravate HIV infection. We examined whether other immunological parameters might influence the viral setpoint.
  
  
  METHODS
  Peripheral T cells from nine untreated patients, obtained after primary HIV infection when plasma HIV had stabilized, were examined for proteins expressed in activated versus resting, memory versus naive, and cytolytic versus non-cytolytic T cells.
  
  
  METHODS
  The proportion of CD8 T cells that stain for CD38 and HLA-DR, CD28 and CD57 was compared with plasma viraemia and CD4 cell count. These parameters were also compared with the proportion of CD4 and CD8 T cells that express CD62L and CD45RA, present on naive cells and down-modulated in memory cells. Internal staining for the cytotoxic protein granzyme A was also examined.
  
  
  RESULTS
  An increase in CD38 and CD38 HLA-DR CD8 T cells correlated with increased plasma viral RNA (P < 0.00002, P < 0.03, respectively). An increase in CD8 T cells expressing granzyme A was associated with lower CD4 cell counts (P < 0.04). However, the expansion of CD57 and CD62L CD45RA+ CD8 T cells was associated with a lower viral setpoint (P < 0.01, P < 0.02, respectively).
  
  
  CONCLUSIONS
  Phenotypically defined activated CD8 T cells may have different functions in HIV infection. Activated CD8 T cells that are CD57 or CD62L(-)CD45RA+ may be beneficial, because their expansion in untreated patients correlates with a reduced viral setpoint after primary infection.
authors.affiliation: The Center for Blood Research, Harvard Medical School, Boston, MA 02115, USA. lieberman@cbr.med.harvard.edu
authors.forename: J
authors.initials: J
authors.lastname: Lieberman
authors.forename: L A
authors.initials: LA
authors.lastname: Trimble
authors.forename: R S
authors.initials: RS
authors.lastname: Friedman
authors.forename: J
authors.initials: J
authors.lastname: Lisziewicz
authors.forename: F
authors.initials: F
authors.lastname: Lori
authors.forename: P
authors.initials: P
authors.lastname: Shankar
authors.forename: H
authors.initials: H
authors.lastname: Jessen
mesh_terms: D000293:Adolescent; D000328:Adult; D000945:Antigens, Differentiation, T-Lymphocyte / Q000032:analysis*; D018791:CD4 Lymphocyte Count; D018959:CD57 Antigens / Q000032:analysis; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D016207:Cytokines / Q000378:metabolism; D005434:Flow Cytometry; D015658:HIV Infections / Q000276:immunology* / Q000821:virology*; D015497:HIV-1 / Q000502:physiology*; D006801:Humans; D019041:L-Selectin / Q000032:analysis; D017493:Leukocyte Common Antigens / Q000032:analysis; D008213:Lymphocyte Activation; D018655:Lymphocyte Count; D012367:RNA, Viral / Q000097:blood*; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D019562:Viral Load
chemical_list: D000945:Antigens, Differentiation, T-Lymphocyte; D018959:CD57 Antigens; D016207:Cytokines; D012367:RNA, Viral; D019041:L-Selectin; D017493:Leukocyte Common Antigens